These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 16181822)

  • 21. Should we inhibit angiotensin-converting enzymes in acute heart failure?
    Lamond NW; Howlett JG
    Heart Fail Monit; 2007; 5(3):70-6. PubMed ID: 17487295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Acute and chronic cardiac decompensation: is vasodilator therapy useful?].
    Malacco E; Limonta A; Milanesi A; Micossi P
    Minerva Med; 1982 Jan; 73(1-2):25-32. PubMed ID: 7058000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical issues in the management of heart failure.
    Boccanelli A; Scardovi AB
    G Ital Cardiol; 1999 Oct; 29(10):1195-8. PubMed ID: 10546133
    [No Abstract]   [Full Text] [Related]  

  • 24. Failure of many new heart-failure drugs: the need for vasoconstrictor rather than vasodilator agents?
    Cleland JG
    Br J Hosp Med; 1994 Sep 7-20; 52(5):193, 195-6. PubMed ID: 7820314
    [No Abstract]   [Full Text] [Related]  

  • 25. Review of vasodilators in acute decompensated heart failure: the old and the new.
    Carlson MD; Eckman PM
    J Card Fail; 2013 Jul; 19(7):478-93. PubMed ID: 23834924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute decompensated heart failure syndromes (ATTEND) registry. A prospective observational multicenter cohort study: rationale, design, and preliminary data.
    Sato N; Kajimoto K; Asai K; Mizuno M; Minami Y; Nagashima M; Murai K; Muanakata R; Yumino D; Meguro T; Kawana M; Nejima J; Satoh T; Mizuno K; Tanaka K; Kasanuki H; Takano T;
    Am Heart J; 2010 Jun; 159(6):949-955.e1. PubMed ID: 20569705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Beneficial effects of early initiation of vasoactive agents in patients with acute decompensated heart failure.
    Saltzberg MT
    Rev Cardiovasc Med; 2004; 5 Suppl 4():S17-27. PubMed ID: 15627915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The treatment targets in acute decompensated heart failure.
    Fonarow GC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S7-S12. PubMed ID: 12439356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute decompensated heart failure: challenges and opportunities.
    Fonarow GC
    Rev Cardiovasc Med; 2007; 8 Suppl 5():S3-12. PubMed ID: 18192951
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Managed care interventions for improving outcomes in acute heart failure syndromes.
    Khan SS; Gheorghiade M; Dunn JD; Pezalla E; Fonarow GC
    Am J Manag Care; 2008 Dec; 14(12 Suppl Managed):S273-86; quiz S287-91. PubMed ID: 19166273
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Digitalis, diuretic and vasodilator treatment of cardiac failure].
    Juillière Y
    Rev Prat; 1997 Dec; 47(19):2125-9. PubMed ID: 9501604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.
    Nieminen MS; Böhm M; Cowie MR; Drexler H; Filippatos GS; Jondeau G; Hasin Y; Lopez-Sendon J; Mebazaa A; Metra M; Rhodes A; Swedberg K; Priori SG; Garcia MA; Blanc JJ; Budaj A; Cowie MR; Dean V; Deckers J; Burgos EF; Lekakis J; Lindahl B; Mazzotta G; Morais J; Oto A; Smiseth OA; Garcia MA; Dickstein K; Albuquerque A; Conthe P; Crespo-Leiro M; Ferrari R; Follath F; Gavazzi A; Janssens U; Komajda M; Morais J; Moreno R; Singer M; Singh S; Tendera M; Thygesen K;
    Eur Heart J; 2005 Feb; 26(4):384-416. PubMed ID: 15681577
    [No Abstract]   [Full Text] [Related]  

  • 33. Nesiritide: the latest drug for treating heart failure.
    Fontana D
    Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
    [No Abstract]   [Full Text] [Related]  

  • 34. Acute heart failure syndromes and coronary perfusion.
    Beohar N; Erdogan AK; Lee DC; Sabbah HN; Kern MJ; Teerlink J; Bonow RO; Gheorghiade M
    J Am Coll Cardiol; 2008 Jul; 52(1):13-6. PubMed ID: 18582629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neurohormonal mechanisms in cardiac insufficiency. Possible therapeutic implications].
    Iannetti MV; Vallebona A; Perocchio M
    Minerva Cardioangiol; 1993 Mar; 41(3):81-9. PubMed ID: 8510813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Chronic heart failure treatment in the year 2006].
    De Berrazueta Fernández JR
    An R Acad Nac Med (Madr); 2006; 123(3):617-30. PubMed ID: 17451101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The failing heart and the hemodynamic response to vasodilator therapy.
    Mills RM
    Clin Cardiol; 2003 Jun; 26(6):257-8. PubMed ID: 12839041
    [No Abstract]   [Full Text] [Related]  

  • 38. Targeting the kidney in acute decompensated heart failure: conventional diuretics and renal-acting vasodilators.
    Martin FL; Chen HH; Cataliotti A; Burnett JC
    Rev Cardiovasc Med; 2008; 9(1):39-45. PubMed ID: 18418308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of disease-modifying therapies in patients hospitalized with heart failure: a population-based perspective.
    Goldberg RJ; Spencer FA; Farmer C; Lessard D; Pezzella SM; Meyer TE
    Am J Med; 2007 Jan; 120(1):98.e1-8. PubMed ID: 17208085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Theory and practice in the treatment of heart failure.
    Taylor SH
    G Ital Cardiol; 1979; 9(5):507-26. PubMed ID: 478222
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.